Saturday, February 22, 2014

ACAD: Acadia Pharmaceuticals ($28.84)

ACAD announced that their 4th quarter conference call will be held on Thursday February 27th at 4:00 p.m. The stock had a strong week gaining +20.52% and has moved up to prior resistance at the $29.00 area on heavy volume.
Bottom Line:  Looking forward to ACAD's 4th quarter conference call on Thursday, and will be listening for any new information regarding timelines related to the FDA process, and any update on the ongoing Alzheimer's phase 2 trial.  We are long term investors of ACAD.

No comments:

Post a Comment